UK markets closed
NIKKEI 225
38,835.10 +599.03 (+1.57%) HANG SENG
18,479.37 -98.93 (-0.53%) CRUDE OIL
78.30 -0.18 (-0.23%) GOLD FUTURES
2,321.70 -9.50 (-0.41%) DOW
38,884.26 +31.99 (+0.08%) Bitcoin GBP
50,387.54 -267.83 (-0.53%)
Elevation Oncology, Inc. (ELEV)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 3.7400 |
| Open | 3.7700 |
| Bid | 3.4700 x 300 |
| Ask | 3.5000 x 500 |
| Day's range | 3.4020 - 3.7700 |
| 52-week range | 0.3630 - 5.8900 |
| Volume | |
| Avg. volume | 1,025,508 |
| Market cap | 190.141M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
Elevation Oncology Inc (ELEV) Reports Financial Results for Q4 and Full Year 2023
Strategic Advances Amidst Financial Prudence
- Simply Wall St.
With 29% ownership in Elevation Oncology, Inc. (NASDAQ:ELEV), hedge funds investors have a lot riding on the business
Key Insights Significantly high institutional ownership implies Elevation Oncology's stock price is sensitive to their...
- Simply Wall St.
Private equity firms among Elevation Oncology, Inc.'s (NASDAQ:ELEV) largest shareholders, saw gain in holdings value after stock jumped 34% last week
Key Insights Elevation Oncology's significant private equity firms ownership suggests that the key decisions are...
© 2024 Yahoo. All rights reserved.